BioSpace News Archive

Aziyo Biologics, Inc. today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will present at the Cowen 43rd Annual Health Care Conference.

Collaborative efforts are aimed at using Lantern’s AI platform to accelerate and sharpen the drug development of TTC-352.

Data infrastructure and analytics company Kalderos, creator of the world’s first Drug Discount Management platform, today introduced a new portal designed exclusively for drug manufacturers to ensure a simplified, more efficient way to process drug discount claims.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in a fireside chat at 43rd Annual Cowen Health Care Conference on Monday, March 6, 2023, at 10:30 a.m. ET.

Lyra Therapeutics, Inc. today announced the appointment of John Bishop, Ph.D., as Chief Technology Officer, effective February 27, 2023.

Apexigen, Inc. today announced that it has engaged Ladenburg Thalmann & Co. Inc. (“Ladenburg”) to evaluate strategic alternatives for the Company with the goal of maximizing stockholder value.

OrthoVentions LLC and the Hospital for Special Surgery announced they have entered into an agreement to support the development of technologies crafted by the premiere musculoskeletal surgeon group.

Gracell Biotechnologies Inc. today announced that it plans to release unaudited financial results for the fourth quarter ended December 31, 2022 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, March 13, 2023.

DarioHealth Corp. (Nasdaq: DRIO) (the “Company”), a leader in the global digital therapeutics (DTx) market, announced today two new clinical studies presented at the 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) 2023, which was held February 22-25 in Berlin.

Evogene Ltd. announced today that it will release its financial results for the fourth quarter and full year 2022 on Thursday, March 9, 2023.